SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) July 6, 2000
SurModics, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Minnesota
(State of Other Jurisdiction of Incorporation)
0-18050 41-1356149
(Commission File Number) (I.R.S. Employer Identification No.)
9942 West 74th Street
Eden Prairie, Minnesota 55344
(Address of Principal Executive Offices) (Zip Code)
(612) 829-2715
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5 Other Events.
On July 6, 2000, SurModics, Inc. issued a press release announcing it
has entered into a licensing and development agreement with Motorola, Inc.'s
BioChip Systems unit which grants Motorola exclusive rights to SurModics'
proprietary PhotoLink(R) technology for use in Motorola's biochips. A copy of
the press release is filed as Exhibit 99 to this Form 8-K.
Item 7. Financial Statements and Exhibits
(a) Financial Statements of Businesses Acquired:
Not Applicable.
(b) Pro Forma Financial Information:
Not Applicable.
(c) Exhibits:
See Exhibit Index on page following Signatures.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SURMODICS, INC.
Date: July 6, 2000 By /s/ James C. Powell
James C. Powell
President & Chief Operating Officer
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
EXHIBIT INDEX
to
FORM 8-K
SURMODICS, INC.
Exhibit Number Exhibit Description
-------------- -------------------
99 Press release dated July 6, 2000.
